Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasms 2Vulvar Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Teratoma, Ovarian 1Struma Ovarii 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Ovarian Neoplasms 1Metabolic Syndrome 1Lung Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Head and Neck Neoplasms 1Genetic Predisposition to Disease 1Disease 1Diabetes Mellitus 1Cardiovascular Diseases 1Carcinoma, Hepatocellular 1

Interventions

Blood Specimen Collection 5Drug Therapy 3Specimen Handling 2Immune Checkpoint Inhibitors 2Carboplatin 2Biopsy, Large-Core Needle 2Biopsy 2toripalimab 1tislelizumab 1taxane 1sacituzumab govitecan 1pembrolizumab 1atezolizumab 1Zoledronic Acid 1Urine Specimen Collection 1Prophylactic Mastectomy 1Paracentesis 1Neuropsychological Tests 1Mifepristone 1Medicine, Chinese Traditional 1Mastectomy, Segmental 1Magnetic Resonance Spectroscopy 1Interviews as Topic 1Immunotherapy 1Immunohistochemistry 1Gene Expression Profiling 1Doxorubicin 1DNA 1Cyclophosphamide 1Combined Modality Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Triple Negative Breast Neoplasms × DNA × Clear all
NCT05111067 2024-08-21

Molecular Subtyping of Triple-negative Breast Cancer and African Ancestry-related Immunogenicity

Nova Scotia Health Authority

Completed
120 enrolled
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡